Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
<p>Abstract</p> <p>Background</p> <p>In developing countries rotavirus is the leading cause of severe diarrhoea and diarrhoeal deaths in children under 5. Vaccination could greatly alleviate that burden, but in Mexico as in most low- and middle-income countries the deci...
Main Authors: | Gutierrez Juan-Pablo, Bertozzi Stefano M, Valencia-Mendoza Atanacio, Itzler Robbin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/8/103 |
Similar Items
-
A predictive model for the utilization of curative ambulatory health services in Mexico Un modelo predictivo de la utilización de servicios de salud ambulatorios curativos en México
by: Atanacio Valencia-Mendoza, et al.
Published: (2008-10-01) -
Costo-efectividad de políticas para el tamizaje de cáncer de mama en México Cost-effectiveness of breast cancer screening policies in Mexico
by: Atanacio Valencia-Mendoza, et al.
Published: (2009-01-01) -
Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh
by: Abdur Razzaque Sarker, et al.
Published: (2018-01-01) -
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)
by: Van Damme Pierre, et al.
Published: (2010-06-01) -
Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia
by: Umid Eraliev, et al.
Published: (2021-02-01)